Session Summary: This webinar will provide an update on the ongoing COVID-19 pandemic by focusing on both ends of spectrum from infection prevention to management of severe disease. Speakers will summarize relevant clinical trial data from COVID-19 vaccination trials and what it means for our patients; and also discuss basic pathophysiology of COVID-19 related acute respiratory distress syndrome and new insights in management via extra corporeal membrane oxygenation (ECMO).
Robin Vos, MD, PhD, University Hospitals Leuven, Leuven, Belgium
Stephanie Pouch, MD, MS, Emory University, Atlanta, GA, USA
Welcome and Introductory Comments
Emily A. Blumberg, MD, University of Pennsylvania, Philadelphia, PA, USA
This talk will summarize current clinical trial data, including effect on viral variants as well as impact on transplant recipients.
ECMO for COVID-19-related ARDS: Evidence and Patient Selection
Daniel Brodie, MD, Columbia University, New York, NY, USA
This talk will explore the emerging evidence for the use of ECMO in patients with COVID-19-related ARDS and how this evidence informs patient selection.
ECMO as a Bridge to Lung Transplantation in COVID-ARDS: To Whom and When?
Marcelo Cypel, MD, University Health Network, Toronto, ON, Canada
This talk will explore when to consider a COVID-ARDS patients on mechanical support for lung transplant assessment and to balance the decisions between the possibility of patient recovery with or without a transplantation.
Live Q & A with All Faculty
Led by Moderator 2
Greg Schultz, CEO, ISHLT, Addison, TX, USA